Profil
Edward Samuel is currently working as the SVP-Technical Operations at Achilles Therapeutics Plc since 2022.
Previously, he worked as the Director-Manufacturing at Cognate BioServices, Inc. from 2015 to 2017 and as the Manager-Cell Therapy Operations at Orchard Therapeutics Plc in 2017.
Dr. Samuel holds a doctorate degree from University College London and a graduate degree from King's College London.
Aktive Positionen von Edward Samuel
| Unternehmen | Position | Beginn |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
Ehemalige bekannte Positionen von Edward Samuel
| Unternehmen | Position | Ende |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01.12.2017 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Corporate Officer/Principal | 01.05.2017 |
Ausbildung von Edward Samuel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
















